Go Pro
→ ALERT: Drop these 5 stocks before the market opens tomorrow! (From Weiss Ratings) (Ad)tc pixel Free IH Stock Alerts

iHuman (IH) Financials

iHuman logo
$1.38 +0.02 (+1.54%)
Closing price 03:57 PM Eastern
Extended Trading
$1.38 0.00 (-0.07%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for iHuman

Annual Income Statements for iHuman

This table shows iHuman's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 -2.56 -40 -7.42 -5.81 16 25 14 14
Consolidated Net Income / (Loss)		 -2.56 -40 -5.76 -5.81 16 25 14 14
Net Income / (Loss) Continuing Operations		 -2.56 -40 -5.76 -5.81 16 25 14 14
Total Pre-Tax Income 		-2.33 -39 -5.69 -5.84 19 29 15 15
Total Operating Income		 -3.21 -40 -6.84 -8.51 16 23 9.85 9.55
Total Gross Profit		 9.61 19 56 104 100 102 88 78
Total Revenue		 19 31 82 148 143 143 126 115
Operating Revenue		 19 31 82 148 143 143 126 115
Total Cost of Revenue		 9.59 12 26 45 43 42 39 37
Operating Cost of Revenue		 9.59 12 26 45 43 42 39 37
Total Operating Expenses		 13 59 63 112 84 79 78 69
Selling, General & Admin Expense		 2.04 27 18 15 16 15 14 13
Marketing Expense		 3.20 7.71 15 32 23 28 30 26
Research & Development Expense		 7.58 24 31 65 45 36 34 30
Total Other Income / (Expense), net		 0.88 0.66 1.14 2.68 3.07 6.01 5.30 5.01
Other Income / (Expense), net		 0.88 0.66 1.14 2.68 3.07 6.01 5.30 5.01
Income Tax Expense		 0.23 0.20 0.07 -0.02 3.33 3.05 1.65 0.91
Basic Earnings per Share		 ($0.11) ($1.52) ($0.21) ($0.14) $0.06 $0.10 $0.05 $0.01
Weighted Average Basic Shares Outstanding		 160M 181.43M 226.34M 266.63M 266.54M 264.05M 262.00M 256.98M
Diluted Earnings per Share		 ($0.11) ($1.52) ($0.21) ($0.14) $0.06 $0.09 $0.05 $0.01
Weighted Average Diluted Shares Outstanding		 160M 181.43M 226.34M 266.63M 270.20M 273.77M 271.20M 267.61M
Weighted Average Basic & Diluted Shares Outstanding		 160M 181.43M 226.34M 267.85M 531.44M 527.41M 520.17M 511.08M

Quarterly Income Statements for iHuman

No quarterly income statements for iHuman are available.

Annual Cash Flow Statements for iHuman

This table details how cash moves in and out of iHuman's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 0.77 14 116 -0.99 28 23 -12 3.98
Net Cash From Operating Activities		 -0.66 6.12 34 6.00 27 24 8.02 7.34
Net Cash From Continuing Operating Activities		 -0.66 6.12 34 6.00 27 24 8.02 7.34
Net Income / (Loss) Continuing Operations		 -2.56 -40 -5.76 -5.81 16 25 14 14
Consolidated Net Income / (Loss)		 -2.56 -40 -5.76 -5.81 16 25 14 14
Depreciation Expense		 0.05 0.09 0.43 1.01 1.57 1.65 1.87 1.11
Non-Cash Adjustments To Reconcile Net Income		 0.03 39 14 6.06 6.07 2.80 0.66 0.81
Changes in Operating Assets and Liabilities, net		 1.83 6.72 25 4.75 3.77 -5.68 -8.02 -8.22
Net Cash From Investing Activities		 -0.08 -0.34 -2.45 -5.01 -4.76 -0.92 -7.23 5.80
Net Cash From Continuing Investing Activities		 -0.08 -0.34 -2.45 -5.01 -4.76 -0.92 -7.23 5.80
Purchase of Property, Plant & Equipment		 -0.08 -0.34 -2.45 -5.07 -0.96 -0.92 -1.02 -0.70
Purchase of Investments		 - - 0.00 0.00 -36 -54 -35 -96
Sale and/or Maturity of Investments		 - - 0.00 0.00 32 54 28 103
Net Cash From Financing Activities		 1.50 8.40 88 0.06 -1.01 -1.33 -14 -8.02
Net Cash From Continuing Financing Activities		 1.50 8.40 88 0.06 -1.01 -1.33 -14 -8.02
Repurchase of Common Equity		 - 0.00 0.00 -0.03 -1.01 -1.34 -1.32 -2.46
Payment of Dividends		 - - - - 0.00 0.00 -4.83 -5.59
Other Financing Activities, net		 -1.58 0.05 -8.86 0.02 0.00 0.01 -7.86 0.03
Effect of Exchange Rate Changes		 - - -3.42 - 6.66 1.07 0.83 -1.14
Cash Income Taxes Paid		 0.00 0.00 0.00 0.07 1.21 3.28 2.99 0.70

Quarterly Cash Flow Statements for iHuman

No quarterly cash flow statements for iHuman are available.

Annual Balance Sheets for iHuman

This table presents iHuman's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 24 161 173 193 204 194 196
Total Current Assets		 23 157 159 182 195 183 186
Cash & Equivalents		 15 133 134 152 171 154 165
Short-Term Investments		 - - - - 0.00 6.23 0.00
Note & Lease Receivable		 - - - 0.00 - 0.00 0.00
Accounts Receivable		 3.01 12 9.25 12 8.82 7.41 7.35
Inventories, net		 2.97 2.60 4.40 2.77 2.33 3.22 3.06
Prepaid Expenses		 2.37 9.94 11 15 13 12 11
Plant, Property, & Equipment, net		 0.36 0.98 1.93 1.33 0.87 0.48 0.37
Total Noncurrent Assets		 0.40 2.94 12 10 8.72 11 9.64
Long-Term Investments		 - - 0.00 3.82 3.71 3.61 3.77
Intangible Assets		 - 1.81 4.28 3.61 3.27 2.25 2.52
Other Noncurrent Operating Assets		 0.38 1.12 6.57 0.93 1.73 5.15 3.35
Total Liabilities & Shareholders' Equity		 24 161 173 193 204 194 196
Total Liabilities		 26 62 77 82 69 63 53
Total Current Liabilities		 26 61 76 81 69 61 52
Accounts Payable		 11 3.39 6.18 3.51 3.12 4.14 3.59
Accrued Expenses		 4.48 16 18 21 20 17 17
Dividends Payable		 - - - - 0.00 0.30 0.00
Current Deferred Revenue		 10 41 48 55 45 39 31
Other Current Liabilities		 0.00 0.24 3.87 1.89 0.90 0.74 0.46
Total Noncurrent Liabilities		 0.00 0.78 1.50 0.42 0.27 1.54 1.32
Other Noncurrent Operating Liabilities		 0.00 - 1.50 0.42 0.27 1.54 1.32
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 -19 99 95 112 135 132 142
Total Preferred & Common Equity		 -19 99 95 112 135 132 142
Total Common Equity		 -19 99 95 112 135 132 142
Common Stock		 31 162 167 156 153 137 137
Retained Earnings		 -50 -59 -66 -47 -20 -5.77 7.61
Accumulated Other Comprehensive Income / (Loss)		 0.00 -3.36 -5.44 1.52 2.53 3.29 2.31
Other Equity Adjustments		 - - 0.10 0.12 -1.20 -2.45 -5.01

Quarterly Balance Sheets for iHuman

No quarterly balance sheets for iHuman are available.

Annual Metrics And Ratios for iHuman

This table displays calculated financial ratios and metrics derived from iHuman's official financial filings.

Metric 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding		 0.00 0.00 266,622,382.00 267,852,667.00 531,444,934.00 527,409,574.00 - 511,083,774.00
DEI Adjusted Shares Outstanding		 0.00 0.00 266,622,382.00 267,852,667.00 531,444,934.00 527,409,574.00 - 511,083,774.00
DEI Earnings Per Adjusted Shares Outstanding		 0.00 0.00 -0.03 -0.02 0.03 0.05 - 0.03
Growth Metrics		 - - - - - - - -
Revenue Growth		 0.00% 63.57% 160.60% 81.21% -3.62% 0.36% -11.90% -8.66%
EBITDA Growth		 0.00% -1,627.06% 86.61% 8.17% 531.09% 44.94% -43.59% -7.99%
EBIT Growth		 0.00% -1,591.33% 85.54% -2.54% 429.80% 48.22% -46.89% -3.94%
NOPAT Growth		 0.00% -1,146.56% 82.92% -24.51% 324.56% 50.29% -56.33% 1.88%
Net Income Growth		 0.00% -1,444.29% 85.43% -0.87% 373.86% 60.03% -46.99% 1.00%
EPS Growth		 0.00% -1,281.82% 86.18% 33.33% 142.43% 56.57% -92.69% -85.60%
Operating Cash Flow Growth		 0.00% 1,033.58% 460.38% -82.52% 355.67% -11.28% -66.91% -8.51%
Free Cash Flow Firm Growth		 0.00% 0.00% 200.93% -100.99% 17,694.75% -19.55% -94.70% 294.89%
Invested Capital Growth		 0.00% 0.00% -92.07% -17.78% -14.80% 10.64% 20.04% 18.02%
Revenue Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
NOPAT Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Income Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Profitability Metrics		 - - - - - - - -
Gross Margin		 50.06% 61.51% 68.70% 69.93% 70.13% 70.84% 69.42% 67.86%
EBITDA Margin		 -11.85% -125.14% -6.43% -3.26% 14.57% 21.04% 13.47% 13.57%
Operating Margin		 -16.73% -127.51% -8.36% -5.74% 11.32% 15.70% 7.80% 8.27%
EBIT Margin		 -12.13% -125.42% -6.96% -3.94% 13.47% 19.90% 11.99% 12.61%
Profit (Net Income) Margin		 -13.35% -126.04% -7.05% -3.92% 11.14% 17.77% 10.69% 11.82%
Tax Burden Percent		 110.07% 100.50% 101.26% 99.61% 82.71% 89.30% 89.14% 93.73%
Interest Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 17.29% 10.70% 10.86% 6.27%
Return on Invested Capital (ROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)		 0.00% 1,907.38% -11.91% -5.98% 15.38% 20.68% 10.13% 9.96%
Cash Return on Invested Capital (CROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)		 0.00% -162.93% -6.15% -3.50% 10.52% 14.35% 7.60% 7.46%
Return on Assets (ROA)		 0.00% -163.74% -6.22% -3.48% 8.70% 12.82% 6.77% 6.99%
Return on Common Equity (ROCE)		 0.00% 17,856.67% -9.78% -5.98% 15.38% 20.68% 10.13% 9.96%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 203.74% -5.83% -6.09% 14.27% 0.00% 10.26% 0.00%
Net Operating Profit after Tax (NOPAT)		 -2.25 -28 -4.79 -5.96 13 20 8.78 8.95
NOPAT Margin		 -11.71% -89.26% -5.85% -4.02% 9.36% 14.02% 6.95% 7.75%
Net Nonoperating Expense Percent (NNEP)		 0.00% -153.37% -1.33% 0.11% 1.75% 3.25% 2.79% 2.83%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - 11.99% 14.91% 6.67% 6.29%
Cost of Revenue to Revenue		 49.94% 38.49% 31.30% 30.07% 29.87% 29.16% 30.58% 32.14%
SG&A Expenses to Revenue		 10.61% 86.64% 21.56% 10.31% 11.08% 10.25% 10.76% 11.33%
R&D to Revenue		 39.51% 77.82% 37.51% 43.96% 31.81% 25.30% 26.87% 25.83%
Operating Expenses to Revenue		 66.79% 189.02% 77.06% 75.67% 58.81% 55.14% 61.62% 59.58%
Earnings before Interest and Taxes (EBIT)		 -2.33 -39 -5.69 -5.84 19 29 15 15
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -2.27 -39 -5.26 -4.83 21 30 17 16
Valuation Ratios		 - - - - - - - -
Price to Book Value (P/BV)		 0.00 0.00 41.49 7.39 5.64 5.27 3.30 3.73
Price to Tangible Book Value (P/TBV)		 0.00 0.00 42.27 7.74 5.83 5.40 3.36 3.80
Price to Revenue (P/Rev)		 4.38 2.68 50.13 4.76 4.41 4.96 3.44 4.60
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 39.54 27.90 32.18 38.89
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 6.24% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 2.53% 3.58% 3.11% 2.57%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)		 0.00 2.75 48.52 3.85 3.31 3.74 2.14 3.14
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 22.74 17.77 15.92 23.13
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 24.59 18.80 17.88 24.89
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 35.38 26.67 30.86 40.49
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 14.10 115.74 95.24 17.33 22.12 33.78 49.36
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 361.23 0.00 24.77 34.87 332.39 112.52
Leverage & Solvency		 - - - - - - - -
Debt to Equity		 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity		 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 0.00 7.26 -1.52 -1.37 -1.40 -1.34 -1.27 -1.21
Leverage Ratio		 0.00 -11.65 1.91 1.72 1.77 1.61 1.50 1.42
Compound Leverage Factor		 0.00 -11.65 1.91 1.72 1.77 1.61 1.50 1.42
Debt to Total Capital		 0.00% 0.00% 0.78% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.78% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% -836.19% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 0.00% 936.19% 99.22% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA		 0.00 0.00 -0.15 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA		 0.00 0.00 25.05 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA		 0.00 0.00 -0.15 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 0.00 0.00 -0.16 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT		 0.00 0.00 27.53 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT		 0.00 0.00 -0.16 0.00 0.00 0.00 0.00 0.00
Altman Z-Score		 0.00 -5.20 40.16 6.26 5.97 7.91 5.77 7.67
Noncontrolling Interest Sharing Ratio		 0.00% -836.19% 17.93% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - -
Current Ratio		 0.00 0.89 2.56 2.10 2.23 2.82 2.98 3.57
Quick Ratio		 0.00 0.69 2.35 1.89 2.02 2.60 2.73 3.30
Cash Flow Metrics		 - - - - - - - -
Free Cash Flow to Firm (FCFF)		 0.00 -11 11 -0.11 19 15 0.82 3.22
Operating Cash Flow to CapEx		 -851.41% 1,782.81% 1,401.90% 119.60% 2,895.47% 2,644.37% 786.17% 1,046.62%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - -
Asset Turnover		 0.00 1.30 0.88 0.89 0.78 0.72 0.63 0.59
Accounts Receivable Turnover		 0.00 10.42 10.87 13.92 13.53 13.86 15.57 15.64
Inventory Turnover		 0.00 4.07 9.21 12.74 11.89 16.40 13.94 11.82
Fixed Asset Turnover		 0.00 87.92 122.12 101.86 87.59 130.16 187.85 273.88
Accounts Payable Turnover		 0.00 1.06 3.45 9.32 8.81 12.62 10.64 9.60
Days Sales Outstanding (DSO)		 0.00 35.03 33.58 26.22 26.99 26.34 23.45 23.34
Days Inventory Outstanding (DIO)		 0.00 89.62 39.65 28.65 30.69 22.26 26.18 30.87
Days Payable Outstanding (DPO)		 0.00 345.79 105.75 39.18 41.44 28.93 34.29 38.02
Cash Conversion Cycle (CCC)		 0.00 -221.14 -32.53 15.68 16.23 19.67 15.34 16.18
Capital & Investment Metrics		 - - - - - - - -
Invested Capital		 0.00 -17 -33 -39 -44 -40 -32 -26
Invested Capital Turnover		 0.00 -3.66 -3.27 -4.14 -3.43 -3.40 -3.53 -3.99
Increase / (Decrease) in Invested Capital		 0.00 -17 -16 -5.85 -5.74 4.73 7.97 5.73
Enterprise Value (EV)		 0.00 86 3,970 571 473 536 271 362
Market Capitalization		 84 84 4,101 705 629 711 435 531
Book Value per Share		 $0.00 ($0.11) $0.44 $0.36 $0.42 $0.25 $0.25 $0.27
Tangible Book Value per Share		 $0.00 ($0.11) $0.43 $0.34 $0.40 $0.25 $0.25 $0.27
Total Capital		 0.00 -2.07 100 95 112 135 132 142
Total Debt		 0.00 0.00 0.78 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt		 0.00 0.00 0.78 0.00 0.00 0.00 0.00 0.00
Net Debt		 0.00 -15 -132 -134 -156 -175 -164 -168
Capital Expenditures (CapEx)		 0.08 0.34 2.45 5.01 0.94 0.92 1.02 0.70
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 0.00 -18 -37 -51 -52 -45 -38 -31
Debt-free Net Working Capital (DFNWC)		 0.00 -2.83 96 84 100 126 122 134
Net Working Capital (NWC)		 0.00 -2.83 96 84 100 126 122 134
Net Nonoperating Expense (NNE)		 0.31 12 0.98 -0.14 -2.54 -5.37 -4.72 -4.70
Net Nonoperating Obligations (NNO)		 0.00 -15 -132 -134 -156 -175 -163 -168
Total Depreciation and Amortization (D&A)		 0.05 0.09 0.43 1.01 1.57 1.65 1.87 1.11
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% -56.98% -45.02% -34.20% -36.25% -31.63% -30.41% -26.85%
Debt-free Net Working Capital to Revenue		 0.00% -9.01% 116.98% 56.35% 70.29% 87.58% 96.32% 115.78%
Net Working Capital to Revenue		 0.00% -9.01% 116.98% 56.35% 70.29% 87.58% 96.32% 115.78%
Earnings Adjustments		 - - - - - - - -
Adjusted Basic Earnings per Share		 $0.00 $0.00 ($0.03) ($0.02) $0.06 $0.10 $0.01 $0.01
Adjusted Weighted Average Basic Shares Outstanding		 0.00 0.00 266.62M 266.63M 266.54M 264.05M 262.00M 256.98M
Adjusted Diluted Earnings per Share		 $0.00 $0.00 ($0.03) ($0.02) $0.06 $0.09 $0.01 $0.01
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 0.00 266.62M 266.63M 270.20M 273.77M 271.20M 267.61M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 ($0.03) $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 0.00 226.34M 267.85M 531.44M 527.41M 520.17M 511.08M
Normalized Net Operating Profit after Tax (NOPAT)		 -2.25 -28 -4.79 -5.96 13 20 8.78 8.95
Normalized NOPAT Margin		 -11.71% -89.26% -5.85% -4.02% 9.36% 14.02% 6.95% 7.75%
Pre Tax Income Margin		 -12.13% -125.42% -6.96% -3.94% 13.47% 19.90% 11.99% 12.61%
Debt Service Ratios		 - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 35.77% 40.97%
Augmented Payout Ratio		 0.00% 0.00% 0.00% -0.44% 6.34% 5.27% 45.54% 58.99%

Quarterly Metrics And Ratios for iHuman

No quarterly metrics and ratios for iHuman are available.


Financials Breakdown Chart

iHuman Financials - Frequently Asked Questions

According to the most recent income statement we have on file, iHuman's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

iHuman's net income appears to be on an upward trend, with a most recent value of $13.64 million in 2025, falling from -$2.56 million in 2018. The previous period was $13.51 million in 2024. View iHuman's forecast to see where analysts expect iHuman to go next.

iHuman's total operating income in 2025 was $9.55 million, based on the following breakdown:
  • Total Gross Profit: $78.31 million
  • Total Operating Expenses: $68.76 million

Over the last 7 years, iHuman's total revenue changed from $19.19 million in 2018 to $115.40 million in 2025, a change of 501.3%.

iHuman's total liabilities were at $53.36 million at the end of 2025, a 15.1% decrease from 2024, and a 103.4% increase since 2019.

In the past 6 years, iHuman's cash and equivalents has ranged from $15.06 million in 2019 to $170.96 million in 2023, and is currently $164.61 million as of their latest financial filing in 2025.

Over the last 7 years, iHuman's book value per share changed from 0.00 in 2018 to 0.27 in 2025, a change of 27.4%.


Related Companies

Financial statements for NYSE:IH last updated on 7/16/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
The $15 Gold Fund That Pays Up to $1,152/Month
Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...
Investors Alley | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...
TradeSmith | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
Elon’s new "tollbooth"
The SpaceX IPO was valued at $1.75 trillion. But one analyst says fighting over those shares may be the wrong ...
Weiss Ratings | Sponsoredtc pixel